Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Fibrogen Inc CS (NQ: FGEN ) 0.3916 +0.0186 (+4.99%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Fibrogen Inc CS < Previous 1 2 3 4 5 6 7 8 9 10 Next > FGEN Stock Earnings: FibroGen Beats EPS, Beats Revenue for Q2 2024 August 06, 2024 FGEN stock results show that FibroGen beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Nasdaq Surges Over 3%; Powell Industries Shares Spike Higher July 31, 2024 Via Benzinga Dow Jumps Over 200 Points; Kraft Heinz Shares Gain After Q2 Earnings July 31, 2024 Via Benzinga Topics Stocks Exposures US Equities One Year, Five Trial Failures: FibroGen Terminates Pancreatic Cancer Treatment Program July 31, 2024 FibroGen reports topline results from late-stage trials of pamrevlumab for pancreatic cancer, failing to meet the primary endpoint of overall survival. Via Benzinga Ground Cinnamon Recalls: What to Know as FDA Issues Alert Over Lead Levels July 31, 2024 New ground cinnamon recalls are in effect as the FDA warns consumers about increased lead levels in some of these products. Via InvestorPlace Topics Product Recall Exposures Legal Product Safety Why Are Chip Stocks Up Today? July 31, 2024 Chip stocks are up today and investors wondering why will find all of the news explaining the rally in the sector on Wednesday. Via InvestorPlace FibroGen Layoffs 2024: What to Know About the Latest FGEN Job Cuts July 31, 2024 FibroGen layoffs are in the news Wednesday after the biopharmaceutical company announced plans to cut jobs after failed clinical trials. Via InvestorPlace Topics Workforce Exposures Layoff Why is Macrogenics (MGNX) Stock Down 28% Today? July 31, 2024 Macrogenics stock is down on Wednesday after MGNX investors learned that the company is discontinuing a Phase 2 clinical trial. Via InvestorPlace Why Is FibroGen (FGEN) Stock Down 44% Today? July 31, 2024 FibroGen stock is down on Wednesday as FGEN investors react to the company's failed clinical trials for its pancreatic cancer treatment. Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday July 31, 2024 It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news happening this morning! Via InvestorPlace Why AMD Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket July 31, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session July 04, 2024 Via Benzinga What's Going On With FibroGen Stock Tuesday? June 04, 2024 FibroGen Inc (NASDAQ:FGEN) shares are trading higher Tuesday morning after the company said the FDA cleared its Investigational New Drug (IND) of FG-3165. FibroGen also announced a new clinical trial... Via Benzinga Exposures Product Safety Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday June 04, 2024 It's time to start Tuesday with a breakdown of the biggest pre-market stock movers traders will want to know about this morning! Via InvestorPlace Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket June 04, 2024 Via Benzinga FibroGen Stock Is Surging After The Bell: What's Going On? June 03, 2024 FibroGen shares are moving higher in Monday's after-hours session after the company announced the FDA cleared its Investigational New Drug (IND) FG-3165. The company also announced a new clinical trial... Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Monday's After-Market Session June 03, 2024 Via Benzinga 7 Penny Biotech Stocks to Triple Your Investment May 28, 2024 Biotech penny stocks offer the chance to triple your investments and require an appetite for risk in order to capture returns. Via InvestorPlace Investor Spotlight: Companies Poised for Growth Amid Recent Developments: VTAK, ESPR, FGEN, GSUN, INBS May 08, 2024 Via AB Newswire Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 07, 2024 Via Benzinga FibroGen Shares Climb On Strong Q1 Sales May 07, 2024 FibroGen reported quarterly losses of 33 cents per share which missed the analyst consensus estimate of $(0.31) and represents a 59.26% increase year-over-year. Quarterly sales clocked in at $55.902... Via Benzinga Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday May 07, 2024 Via Benzinga Why Zeta Global Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket May 07, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 07, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday May 07, 2024 It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to keep an eye on for Tuesday! Via InvestorPlace FGEN Stock Earnings: FibroGen Beats EPS, Beats Revenue for Q1 2024 May 06, 2024 FGEN stock results show that FibroGen beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Monday's After-Market Session May 06, 2024 Via Benzinga Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session April 03, 2024 Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly... Via Benzinga Exposures Glyphosate 12 Health Care Stocks Moving In Wednesday's Intraday Session April 03, 2024 Via Benzinga FibroGen Unveils Early Data From Prostate Cancer Candidate, Analyst Advocates Further Exploration In The Landscape April 03, 2024 FibroGen reveals Phase 1 results for FG-3246 for metastatic castration-resistant prostate cancer. Promising efficacy metrics and plans for enhanced therapeutic strategies signal potential advancements... Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.